Schweitzer Fachinformationen
Wenn es um professionelles Wissen geht, ist Schweitzer Fachinformationen wegweisend. Kunden aus Recht und Beratung sowie Unternehmen, öffentliche Verwaltungen und Bibliotheken erhalten komplette Lösungen zum Beschaffen, Verwalten und Nutzen von digitalen und gedruckten Medien.
Maria Vallet-Regi is full Professor of Inorganic Chemistry and Head of the Department of Inorganic and Bioinorganic Chemistry of the Faculty of Pharmacy at Universidad Complutense de Madrid, Spain.
Professor Vallet-Regí has written over 500 articles and more than 20 books. She is the most cited Spanish scientist in the field of Materials Science in this last decade, according to ISI Web of Knowledge. She has presented her research around the world at over 300 international conferences Professor Vallet-Regí has received many awards including: the French-Spanish award of the year 2000 from the Societé Française de Chimie; the Inorganic Chemistry award 2008 from the Spanish Royal Society of Chemistry; the 2008 Spanish National Research Award "Leonardo Torres Quevedo" in the field of Engineering and Spanish Royal Society of Chemistry (RSEQ) research award 2011 (RSEQ medal).
Preface xv
Part I Introduction 1
1. Bioceramics 3María Vallet-Regí
1.1 Introduction 3
1.2 Reactivity of the Bioceramics 4
1.3 First, Second, and Third Generations of Bioceramics 6
1.4 Multidisciplinary Field 7
1.5 Solutions for Bone Repairing 8
1.6 Biomedical Engineering 13
Recommended Reading 15
2. Biomimetics 17María Vallet-Regí
2.1 Biomimetics 17
2.2 Formation of Hard Tissues 18
2.3 Biominerals versus Biomaterials 19
Recommended Reading 22
Part II Materials 23
3. Calcium Phosphate Bioceramics 25Daniel Arcos
3.1 History of Calcium Phosphate Biomaterials 25
3.2 Generalities of Calcium Phosphates 26
3.3 In vivo Response of Calcium Phosphate Bioceramics 28
3.4 Calcium Hydroxyapatite-Based Bioceramics 30
3.4.1 Stoichiometric Hydroxyapatite (HA) 31
3.4.2 Calcium Deficient Hydroxyapatites (CDHA) 37
3.4.3 Carbonated Hydroxyapatites (CHA) 39
3.4.4 Silicon-Substituted Hydroxyapatite (Si-HA) 40
3.4.5 Hydroxyapatites of Natural Origin 45
3.5 Tricalcium Phosphate-Based Bioceramics 50
3.5.1 -Tricalcium Phosphate (-TCP) 50
3.5.2 -Tricalcium Phosphate (-TCP) 53
3.6 Biphasic Calcium Phosphates (BCP) 55
3.6.1 Chemical and Structural Properties 55
3.6.2 Preparation Methods 56
3.6.3 Clinical Applications 56
3.7 Calcium Phosphate Nanoparticles 57
3.7.1 General Properties and Scope of Calcium Phosphate Nanoparticles 57
3.7.2 Preparation Methods of CaP Nanoparticles 58
3.7.3 Clinical Applications 60
3.8 Calcium Phosphate Advanced Biomaterials 60
3.8.1 Scaffolds for in situ Bone Regeneration and Tissue Engineering 60
3.8.2 Drug Delivery Systems 62
References 65
4. Silica-based Ceramics: Glasses 73Antonio J. Salinas
4.1 Introduction 73
4.1.1 What Is a Glass? 73
4.1.2 Properties of Glasses 75
4.1.3 Structure of Glasses 75
4.1.4 Synthesis of Glasses 76
4.2 Glasses as Biomaterials 78
4.2.1 First Bioactive Glasses (BGs): Melt-Prepared Glasses (MPGs) 79
4.2.2 Other Bioactive MPGs 80
4.2.3 Bioactivity Index and Network Connectivity 80
4.2.4 Mechanism of Bioactivity 81
4.3 Increasing the Bioactivity of Glasses: New Methods of Synthesis 82
4.3.1 Sol-Gel Glasses (SGGs) 82
4.3.2 Composition, Texture, and Bioactivity of SSGs 84
4.3.3 Biocompatibility of SGGs 86
4.3.4 SGGs as Bioactivity Accelerators in Biphasic Materials 86
4.3.5 Template Glasses (TGs) Bioactive Glasses with Ordered Mesoporosity 88
4.3.6 Atomic Length Scale in BGs: How the Local Structure Affects Bioactivity 91
4.3.7 New Reformulation of Hench's Mechanism for TGs 93
4.3.8 Including Therapeutic Inorganic Ions in the Glass Composition 94
4.4 Strengthening and Adding New Capabilities to Bioactive Glasses 95
4.4.1 Glass Ceramics (GCs) 95
4.4.2 Composites Containing Bioactive Glasses 97
4.4.3 Sol-Gel Organic-Inorganic Hybrids (O-IHs) 98
4.5 Non-silicate Glasses 99
4.5.1 Phosphate Glasses 99
4.5.2 Borate Glasses 100
4.6 Clinical Applications of Glasses 101
4.6.1 Bioactive Silica Glasses 101
4.6.2 Inert Silica Glasses 106
4.6.3 Phosphate Glasses 106
4.6.4 Borate Glasses 107
Recommended Reading 107
5. Silica-based Ceramics: Mesoporous Silica 109Montserrat Colilla
5.1 Introduction 109
5.2 Discovery of Ordered Mesoporous Silicas 110
5.3 Synthesis of Ordered Mesoporous Silicas 111
5.3.1 Hydrothermal Synthesis 112
5.3.2 Evaporation-Induced Self-Assembly (EISA) Method 119
5.4 Mechanisms of Mesostructure Formation 119
5.5 Tuning the Structural Properties of Mesoporous Silicas 122
5.5.1 Micellar Mesostructure 123
5.5.2 Type of Mesoporous Structure 128
5.5.3 Mesopore Size 131
5.6 Structural Characterization of Mesoporous Silicas 132
5.7 Synthesis of Spherical Mesoporous Silica Nanoparticles 135
5.7.1 Aerosol-Assisted Synthesis 136
5.7.2 Modified Stöber Method 137
5.8 Organic Functionalization of Ordered Mesoporous Silicas 138
5.8.1 Post-synthesis Functionalization ("Grafting") 139
5.8.2 Co-condensation ("One-Pot" Synthesis) 140
5.8.3 Periodic Mesoporous Organosilicas 141
References 141
6. Alumina, Zirconia, and Other Non-oxide Inert Bioceramics 153Juan Peña López
6.1 A Perspective on the Clinical Application of Alumina and Zirconia 153
6.1.1 Alumina 155
6.1.2 Zirconia 158
6.2 Novel Strategies Based on Alumina and Zirconia Ceramics 160
6.2.1 From Alumina Toughened Zirconia to Alumina Matrix Composite 160
6.2.2 Introduction of Different Species in Zirconia 161
6.2.3 Improvement of Surface Adhesion 162
6.3 Non-oxidized Ceramics 163
6.3.1 Silicon Nitride (Si3N4) 163
6.3.2 Silicon Carbide (SiC) 164
References 164
7. Carbon-based Materials in Biomedicine 175Mercedes Vila
7.1 Introduction 175
7.2 Carbon Allotropes 175
7.2.1 Pyrolytic Carbon 176
7.2.2 Carbon Fibers 177
7.2.3 Fullerenes 177
7.2.4 Carbon Nanotubes 179
7.2.5 Graphene 181
7.2.6 Diamond and Amorphous Carbon 184
7.3 Carbon Compounds 186
7.3.1 Silicon Carbide 186
7.3.2 Boron Carbide 187
7.3.3 Tungsten Carbide 188
References 188
Part III Material Shaping 193
8. Cements 195Oscar Castaño and Josep A. Planell
Abbreviations 195
Glossary 196
8.1 Introduction 197
8.1.1 Brief History 197
8.1.2 Definition and Chemistry 199
8.1.3 Description of the Different CaP Cements 200
8.1.4 State of the Art 201
8.2 Calcium Phosphate Cements 206
8.2.1 Types 206
8.2.2 Mechanisms 206
8.2.3 Relevant Experimental Variables 207
8.2.4 Material Characterization 211
8.2.5 Reaction Evolution of Cements 220
8.2.6 Additives and Strategies to Enhance Properties 222
8.2.7 Biological Characterization and Bioactive Behavior 224
8.3 Applications 229
8.3.1 Bone Defect Repair 229
8.3.2 Drug Delivery Systems 232
8.4 Future Trends 232
8.5 Conclusions 233
References 234
9. Bioceramic Coatings for Medical Implants 249M. Victoria Cabañas
9.1 Introduction 249
9.2 Methods to Modify the Surface of an Implant 250
9.2.1 Deposited Coatings 251
9.2.2 Conversion Coatings 257
9.3 Bioactive Ceramic Coatings 258
9.3.1 Clinical Applications 259
9.3.2 Calcium Phosphates-Based Coatings 260
9.3.3 Silica-based Coatings: Glass and Glass-Ceramics 268
9.3.4 Bioactive Ceramic Layer Formation on a Metallic Substrate 270
9.4 Bioinert Ceramic Coatings 272
9.4.1 Titanium Nitride and Zirconia Coatings 273
9.4.2 Carbon-based Coatings 275
References 279
10. Scaffold Designing 291Isabel Izquierdo-Barba
10.1 Introduction 291
10.2 Essential Requirements for Bone Tissue Engineering Scaffolds 293
10.3 Scaffold Processing Techniques 296
10.3.1 Foam Scaffolds 297
10.3.2 Rapid Prototyping Scaffolds 301
10.3.3 Electrospinning Scaffolds 305
References 307
Part IV Research on Future Ceramics 315
11. Bone Biology and Regeneration 317Soledad Pérez-Amodio and Elisabeth Engel
11.1 Introduction 317
11.2 The Skeleton 318
11.3 Bone Remodeling 320
11.4 Bone Cells 322
11.4.1 Bone Lining Cells 322
11.4.2 Osteoblasts 323
11.4.3 Osteocytes 323
11.4.4 Osteoclasts 324
11.5 Bone Extracellular Matrix 327
11.6 Bone Diseases 327
11.6.1 Osteoporosis 328
11.6.2 Paget's Disease 329
11.6.3 Osteomalacia 329
11.6.4 Osteogenesis Imperfecta 329
11.7 Bone Mechanics 329
11.8 Bone Tissue Regeneration 333
11.8.1 Calcium Phosphate and Silica-based Bioceramics 333
11.8.2 Bioactive Glasses 334
11.8.3 Calcium Phosphate Cements 335
11.9 Conclusions 336
References 336
12. Ceramics for Drug Delivery 343Miguel Manzano
12.1 Introduction 343
12.2 Drug Delivery 344
12.3 Drug Delivery from Calcium Phosphates 346
12.3.1 Drug Delivery from Hydroxyapatite 346
12.3.2 Drug Delivery from Tricalcium Phosphates 348
12.3.3 Drug Delivery from Calcium Phosphate Cements 348
12.4 Drug Delivery from Silica-based Ceramics 351
12.4.1 Drug Delivery from Glasses 351
12.4.2 Drug Delivery from Mesoporous Silica 355
12.5 Drug Delivery from Carbon Nanotubes 363
12.6 Drug Delivery from Ceramic Coatings 365
References 366
13. Ceramics for Gene Transfection 383Blanca González
13.1 Gene Transfection 383
13.2 Gene Transfection Based on Nonviral Vectors 386
13.3 Ceramic Nanoparticles for Gene Transfection 388
13.3.1 Calcium Phosphate Nanoparticles 391
13.3.2 Mesoporous Silica Nanoparticles 393
13.3.3 Carbon Allotropes (Fullerenes, CNTs, Graphene Oxide) 397
13.3.4 Magnetic Iron Oxide Nanoparticles 403
References 410
14. Ceramic Nanoparticles for Cancer Treatment 421Alejandro Baeza
14.1 Delivery of Nanocarriers to Solid Tumors 421
14.1.1 Special Issues of Tumor Vasculature: Enhanced Permeation and Retention Effect (EPR) 422
14.1.2 Tumor Microenvironment 423
14.2 Ceramic Nanoparticle Pharmacokinetics in Cancer Treatment 424
14.2.1 Biodistribution and Excretion/Clearance Pathways 424
14.2.2 Toxicity of the Ceramic Nanoparticles 426
14.3 Cancer-targeted Therapy 428
14.3.1 Endocytic Mechanism of Targeted Drug Delivery 428
14.3.2 Specific Tumor Active Targeting 430
14.3.3 Angiogenesis-associated Active Targeting 432
14.4 Ceramic Nanoparticles for Cancer Treatment 434
14.4.1 Mesoporous Silica Nanoparticles 434
14.4.2 Calcium Phosphates Nanoparticles 440
14.4.3 Carbon Allotropes 440
14.4.4 Iron Oxide Nanoparticles and Hyperthermia 442
14.5 Imaging and Theranostic Applications 443
References 446
Index 457
María Vallet-Regí
Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, Universidad Complutense de Madrid, CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Spain
Ceramic materials are important sources of biomaterials for applications in biomedical engineering. Those ceramics intended to be in contact with living tissues are called bioceramics, and have experienced great development in the last 50 years. The medical needs of an increasingly aging population have driven a great deal of research work looking for new materials for the manufacture of implants. These are used to regenerate and repair living tissues damaged by disease or trauma. For specific clinical applications, mainly in orthopedics and dentistry, bioceramics are playing a key role.
In general, ceramics are inorganic materials with a combination of ionic and covalent bonding. The use of new ceramic materials represents an evolution of many aspects of mankind history. Many millennia ago, the possibility to store grains in ceramic receptacles allowed man to become a settler instead of a nomad hunter. Some centuries ago, the use of structural ceramics also brought great advances in the quality of life of man with the possibility of making clay bricks and tiles. Decades ago, ceramics produced a new revolution in the human way of life, with the development of functional ceramics in dielectrics, semiconductors, magnets, piezoelectrics, high temperature superconductors, and so on. In addition, ceramics have played an important role in improving the quality and length of human life through their use in biomaterials and medical devices.
As observed, the investigation of bioceramics has also evolved when, as will be explained later, more restrictive properties for the new ceramics were required. Thus, alumina, zirconia, calcium phosphates, and certain glasses and glass-ceramics are genuine examples of bioceramics. Figure 1.1 shows a classification of bioceramics according to their reactivity and their main clinical applications. Carbon is an element, not a compound, and conducts electricity in its graphite form, but it is considered a ceramic because of its many ceramic-like properties. Nowadays, new advanced bioceramics are under study, including ordered mesoporous silica materials or specific compositions of organic–inorganic hybrids.
Figure 1.1 Classification of bioceramics according to their reactivity. Particle size, crystallinity, and porosity are important factors to classify certain bioceramics, like apatites, in one group or the other. HA: hydroxyapatite, HCA: hydroxycarbonate apatite, A-W: apatite–wollastonite, TCP: tricalcium phosphate, OCP: octacalcium phosphate, DCPA: dicalcium phosphate anhydrous, DCPD: dicalcium phosphate dihydrate, TetCP: tetracalcium phosphate monoxide (See insert for color representation of the figure)
Ceramic materials have high melting temperatures, low conduction of electricity and heat and relatively high hardness. With regards to their mechanical behavior, ceramic materials exhibit great compression strengths and very much lower tensile strengths. Moreover, they are stiff materials, with high Young's modulus, and brittle because failure takes place without plastic deformation.
In relation to their surface properties, ceramics show high wetting degrees and surface tensions which favor the adhesion of proteins, cells, and other biological moieties. Furthermore, a ceramic surface can be treated to reach very high polish limits. Currently, as will be explained latter, much research effort is devoted to ceramics with interconnected porosity and in these cases the mechanical properties will change drastically.
Nowadays, it is possible to manufacture implants to replace any part of our body, except the brain.
Obviously, different types of materials are in use depending on the tissue to be replaced. Regarding the materials to be used, it is critical to bear in mind that a group of biomaterials will be applied in body reconstruction functions, hence they must perform their duty for an undefined period of time, that is, for the rest of the patient's life. Another group of biomaterials will be used in temporary body support functions. This “permanent” or “temporary” feature allows for a larger and better choice of materials for implant manufacture.
Many different factors affect the reactivity of any chemical substance and greatly determine its reaction kinetics. Figure 1.2 shows some of these. If we take into account the almost inert or bioactive nature of the different ceramics for medical applications, as well as kinetic factors such as particle size and porosity, three groups of bioceramics in use nowadays may be distinguished, inert, bioactive, and biodegradable, as we can see in Figure 1.1. The final purpose of the artificial synthesis of ceramics for bone replacement (hard tissue) is to implant a ceramic material able to regenerate the damaged bone. This is feasible if the ceramic is bioactive. Otherwise, if the ceramic is inert, the bone will be replaced by a material that the organism can tolerate, but which cannot substitute it by means of bone regeneration.
Figure 1.2 Governing factors in chemical reactivity of bioceramics. Composition in between glasses (disordered) and crystals (ordered) (See insert for color representation of the figure)
Reactivity, rather than the type of bioceramic is a suitable criterion to classify bioceramics. For instance, in the field of amorphous ceramics it is possible to obtain glasses that, in the same chemical system, behave as bioinert, bioactive, or resorbable because they have somewhat different compositions. It is also possible to find glasses with identical composition behaving as bioinert when obtained by melting, or bioactive when synthesized by a sol–gel method. Moreover, some glass compositions considered bioactive can be completely resorbed when used as particulates under a certain size limit, for instance, 90 µm for Bioglass® 45S5 (all this will be dealt with in Chapter 4). Analogous examples can be found among crystalline ceramics. For instance, the in vivo reactivity of hydroxyapatite (HA) can range from almost bioinert, when highly sintered as dense monoliths, to resorbable, when used in particle size, omitting the bioactive character generally attributed to HA (to be discussed in Chapter 3).
When some glass compositions presenting the highest levels of bioactivity were investigated, it was found that they were able to bond to hard and soft tissues, whereas other bioactive materials only bond to hard tissues. To explain these differences in reactivity Hench defined in 1994 two classes of bioactivity: class A, osteoproductive and class B, osteoconductive. The first occurs when the material elicits extracellular and intracellular responses whereas in the second only an extracellular response is obtained. It was explained that the ions released from these bioactive glasses, in particulate form, stimulated a regeneration of living tissues mediated by genes. These osteoproductive glasses were considered as third generation bioceramics and are the basis of the research efforts looking for new biomaterials that stimulate the cellular response. Nowadays the research efforts are concentrated on porous second generation bioceramics and new advanced bioceramics. In these materials the ceramic plays the role of a scaffold of cells and substances with biological activity (growth factors, hormones…) which are released to the medium in a controlled way. Thus, they are starting to be used in applications related to tissue engineering.
On the other hand, bioceramics must be biocompatible and functional for the required implantation time. They must also not be toxic, carcinogenic, allergic, or inflammatory. In general, because of their ionic bonds and chemical stability ceramic materials are biocompatible.
The study of bioceramics can be divided into first, second, and third generations. The study of first generation bioceramics started in the 1960s, when the goal was reactivity as low as possible. The more representative examples of this kind of bioceramics are alumina, Al2O3 and zirconia, ZrO2. They are widely used as biomaterials because of their high strength, excellent corrosion and wear resistances, stability, non-toxicity, and in vivo biocompatibility. Around the 1980s the objective changed to obtain favorable interactions with the living body, namely a bioactive response or degradation. Specific compositions of calcium phosphates or sulfates, bioactive glasses, and glass-ceramics are examples of second generation bioceramics used clinically for bone tissue augmentation, as bone cements, or for metallic implants coating. As was indicated, in the last decade bioceramics with more demanding properties were required. The studies in third generation bioceramics are more based in biology and follow the purpose of substituting “replacement” tissues by “regenerating” tissues. This category includes bioceramics based on porous second generation bioceramics, loaded with biologically active substances, and new advanced bioceramics like silica mesoporous materials, mesoporous ordered glasses, or organic–inorganic...
Dateiformat: ePUBKopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „fließenden” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.